Yasumasa Iwatani
Overview
Explore the profile of Yasumasa Iwatani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kidiga M, Murata M, Grover P, Ode H, Iwatani Y, Seki Y, et al.
J Infect Dis
. 2025 Mar;
PMID: 40042867
Background: Primate T-cell leukemia virus type 1 (PTLV-1) is classified into a genus Deltaretrovirus that persists in infected primates and can lead to adult T cell leukemia and inflammatory diseases....
2.
Suzuki N, Iwatani Y, Matsuno K, Nishimura H, Watanabe T, Yamada M
Uirusu
. 2025 Mar;
74(2):141-148.
PMID: 40024796
The virus nomenclature working group (VNWG) was launched to officially fix Japanese names of important viruses under the Japanese Society for Virology (JSV) in 2022. VNWG first determined the priority...
3.
Grover P, Murata M, Kidiga M, Hayashi S, Ode H, Iwatani Y, et al.
J Infect Dis
. 2025 Feb;
PMID: 39903679
Background: Spontaneous remission once a retroviral infection has been established does not occur and infection persists lifelong. Methods: Stored blood samples obtained from simian T-cell leukemia virus type 1 (STLV-1)-infected...
4.
Iwatani Y, Matsuoka K, Ode H, Kubota M, Nakata Y, Setoyama Y, et al.
mBio
. 2025 Jan;
16(3):e0333224.
PMID: 39835817
The human cellular cytidine deaminases APOBEC3s (A3s) inhibit virion infectivity factor (Vif)-deficient HIV-1 replication. However, virus-encoded Vifs abolish this defense system by specifically recruiting A3s to an E3 ubiquitin ligase...
5.
Ode H, Matsuda M, Shigemi U, Mori M, Yamamura Y, Nakata Y, et al.
Sci Rep
. 2024 May;
14(1):12099.
PMID: 38802662
HIV-1 drug resistance genotypic tests have primarily been performed by Sanger sequencing of gene segments encoding different drug target proteins. Since the number of targets has increased with the addition...
6.
Aboshi M, Matsuda K, Kawakami D, Kono K, Kazami Y, Sekida T, et al.
iScience
. 2024 Feb;
27(2):108964.
PMID: 38352232
Continuing emergence of variants of concern resulting in reduced SARS-CoV-2 vaccine efficacy necessitates additional prevention strategies. The structure of VLPCOV-01, a lipid nanoparticle-encapsulated, self-amplifying RNA COVID-19 vaccine with a comparable...
7.
Ito Y, Lu H, Kitajima M, Ishikawa H, Nakata Y, Iwatani Y, et al.
J Nat Prod
. 2023 Oct;
86(11):2487-2495.
PMID: 37874155
The emergence of drug-resistant viruses is a serious concern in current chemotherapy for human immunodeficiency virus type-1 (HIV-1) infectious diseases. Hence, antiviral drugs aiming at targets that are different from...
8.
Uno S, Gatanaga H, Hayashida T, Imahashi M, Minami R, Koga M, et al.
J Antimicrob Chemother
. 2023 Oct;
78(12):2859-2868.
PMID: 37856677
Background: Integrase strand transfer inhibitors (INSTIs) are recommended as first-line ART for people living with HIV (PLWH) in most guidelines. The INSTI-resistance-associated mutation E157Q, a highly prevalent (2%-5%) polymorphism of...
9.
Akahata W, Sekida T, Nogimori T, Ode H, Tamura T, Kono K, et al.
Cell Rep Med
. 2023 Aug;
4(8):101134.
PMID: 37586325
VLPCOV-01 is a lipid nanoparticle-encapsulated self-amplifying RNA (saRNA) vaccine that expresses a membrane-anchored receptor-binding domain (RBD) derived from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. A phase...
10.
Sugimoto A, Watanabe T, Matsuoka K, Okuno Y, Yanagi Y, Narita Y, et al.
Microbiol Spectr
. 2023 Jul;
11(4):e0044023.
PMID: 37409959
The growth transformation of primary B cells by Epstein-Barr virus (EBV) is the initial step in the development of posttransplant lymphoproliferative disorder (PTLD). We performed electron microscopic analysis and immunostaining...